It is fair to say that Reta research products may cost much less than private Mounjaro pricing
Semaglutide 24 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet, 2021
Retatrutide and High Blood Pressure: Evidence, Cautions, and UK Guidance Retatrutide and high blood pressure is an emerging area of clinical interest, as this investigational triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously has shown modest blood pressure reductions in early Phase 2 trials
Semaglutide has been shown to: Significantly decrease appetite Lower blood sugar levels Enhance insulin secretion Reduced inflammatory marker, C-reactive protein Improve heart, liver, and lung function Neuroprotective effects These products are supplied strictly for laboratory research and development purposes only
Your medical provider will evaluate your needs before offering a prescription
So, this is not an epidemic of tendon injuries